Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Medicina Clinica|February 24, 2021
[Glucocorticoids alone versus tocilizumab alone or glucocorticoids plus tocilizumab in patients with severe SARS-CoV-2 pneumonia and mild inflammation]Ismael Francisco Aomar-Millán, Juan Salvatierra, Úrsula Torres-Parejo, et al.
Medicina Clinica (English Ed.)|May 31, 2021
Glucocorticoids alone versus tocilizumab alone or glucocorticoids plus tocilizumab in patients with severe SARS-CoV-2 pneumonia and mild inflammationIsmael Francisco Aomar-Millán, Juan Salvatierra, Úrsula Torres-Parejo, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|August 1, 2026
Rothia spp.: An unusual cause of infective endocarditisJavier Martínez de Victoria Carazo, Antonio García-Chamón Boronat, Francisco Anguita Santos, et al.
European Journal of Hospital Pharmacy : Science and Practice|August 26, 2020
Dalbavancin is a novel antimicrobial against Gram-positive pathogens: clinical experience beyond labelled indicationsMaría Núñez-Núñez, Inmaculada Casas-Hidalgo, Ricardo García-Fumero, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|May 23, 2025
External validation of the HANDOC score in a Spanish cohort-Analysis of blood culture scoring and time to positivityPedro Manuel García-Ceberino, Francisco Anguita-Santos, Jara Llenas-García, et al.
Internal and Emergency Medicine|January 5, 2021
Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort studyIsmael Francisco Aomar-Millán, Juan Salvatierra, Úrsula Torres-Parejo, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|May 27, 2026
ASP-COMPLEX: redefining antimicrobial stewardship to improve outcomes in high-risk patients with severe infectionsJuan Pasquau, Francisco Javier Candel, José Luis Del Pozo, et al.
Clinical and Experimental Rheumatology|October 18, 2016
Effects of rituximab in connective tissue disorders related interstitial lung diseaseGemma Lepri, Jerome Avouac, Paolo Airò, et al.
BMJ Open|August 2, 2020
Quasiexperimental intervention study protocol to optimise the use of new antibiotics in Spain: the NEW_SAFE projectZaira R Palacios-Baena, Lucia Valiente de Santis, Natalia Maldonado, et al.
Jac-Antimicrobial Resistance|November 26, 2025
How to use novel antimicrobials beyond official indications: an expert consensusPilar Retamar-Gentil, María Alegre-Albendea, Lucía Valiente De Santis, et al.
Pageof 2